Ten years after he and his wife experienced a pregnancy loss, Eli Schiff still gets a bit choked up talking about his experience with miscarriage. “You’re imagining all the things that he or she could be, you know, and that imagination or that idea of what they could have been, it doesn’t really go away,” he says of the grief associated with miscarriage.

For more than three decades, the federal government sought to make amends to countless Americans who developed cancer after being exposed to radiation from nuclear testing in the Southwest or while working in the uranium mining industry.

“Can you imagine a day when you turn on your faucet and no water comes out?” The hypothetical question, posed by a research team at UNLV, is called a “Day Zero” scenario. It sounds like the plot of a doomsday apocalypse series but it’s not as unimaginable - or as far-fetched - as a Hollywood screenplay might seem.

As the temperature starts to drop in southern Nevada, we were wondering if the colder weather can really make you sick? Dr. David Weismiller, a professor of family medicine at UNLV, joined ARC Las Vegas and Evan Schreiber to talk about the correlation.

Once medical students have completed medical school and received their medical degree, what is the next step? Could they immediately start their own practice and see patients?

The study was led by Mary Froehlich, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas.

The Down Syndrome Connections Las Vegas announced DS Connect24, the 3rd Annual Las Vegas Down Syndrome Conference was held on Saturday. October is Down Syndrome Awareness Month. The event was held at the Kirk Kerkorian School of Medicine on the campus of UNLV.

A new survey shows one-third of former professional football players believe they have the degenerative brain disease known as chronic traumatic encephalopathy, or CTE. The research, published in the medical journal JAMA Neurology, represents one of the latest expansive surveys on cognitive health issues caused by contact sports.

The first alert about the horror typically comes from a call, text, or emergency radio transmission that might seem unremarkable: There’s been a shooting; prepare to treat some victims. The initial message often conveys little sense of mass tragedy, no warning that the health care team is about to go through a challenge that will test and change them.

On September 26, 2024, the US Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride), formerly known as KarXT, for the treatment of schizophrenia in adults. In doing so, this new agent represents the first medication for schizophrenia in more than 30 years with a novel mechanism of action.

Molina Healthcare of Nevada (“Molina”), in collaboration with The MolinaCares Accord, has announced a $350,000 grant to UNLV Health, expanding access to care at UNLV Health’s ear, nose and throat (ENT) clinic in Las Vegas. Grant funding has helped hire the clinic’s first nurse navigator dedicated to assisting patients and their families. The funds will nearly double the number of ENT clinic patient exam rooms with specialized equipment to treat complex care needs.

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug.